Policy Notices

• RESCINDED - Clarification and Guidance for Applicants Preparing Applications for the Summer 2022 Due Dates During the COVID-19 Pandemic
  (NOT-OD-22-112)
  National Institutes of Health
  

• Notice of Legislative Mandates in Effect for FY 2022
  (NOT-OD-22-117)
  National Institutes of Health
  

• Updated Requirements for NIH Notification of Removal or Disciplinary Action Involving Program Directors/Principal Investigators or other Senior/Key Personnel
  (NOT-OD-22-129)
  National Institutes of Health
  

• June 2022 Updated eRA RPPR Module and Instruction Guide: Action Required for In-Progress Budget Forms
  (NOT-OD-22-130)
  National Institutes of Health
  

• Correction to Stipend Levels for Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2022
  (NOT-OD-22-132)
  Office of the Director, NIH
  

General Notices

• Notice of NICHD Participation in PAR-22-116, International Bioethics Research Training Program (D43 Clinical Trial Optional)"
  (NOT-HD-22-020)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Updated NHLBI Guidance Concerning Mentored Career Development (K08 and K23) Awards: Percent Effort
  (NOT-HL-22-022)
  National Heart, Lung, and Blood Institute
  

• Notice of Availability of FAQ for RFA-MH-22-110 and RFA-MH-22-111: Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes Consortium
  (NOT-MH-22-240)
  National Institute of Mental Health
  

• Request for Public Comments on DRAFT Supplemental Information to the NIH Policy for Data Management and Sharing: Protecting Privacy When Sharing Human Research Participant Data
  (NOT-OD-22-131)
  Office of the Director, NIH
  

Notice of Changes to Funding Opportunities

• Notice of Clarification for PAS-21-245 Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
  (NOT-AR-22-021)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Allergy and Infectious Diseases
  

• Notice of Change to Foreign Component Eligibility in PAR-20-217, PAR-20-218, and PAR-21-240
  (NOT-AT-22-023)
  National Center for Complementary and Integrative Health
  

• Notice of Change to PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"
  (NOT-DA-22-068)
  National Institute on Drug Abuse
  National Cancer Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  

• Notice of Change to PAR-20-101 "Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)"
  (NOT-HD-22-007)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NICHD Participation in NOT-CA-22-037, Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research"
  (NOT-HD-22-019)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Change Key Dates for PAR-20-111 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)"
  (NOT-NS-22-097)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Change Key Dates for PAR-20-122 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)"
  (NOT-NS-22-098)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Point-of-Care Technologies Research Network Centers (U54 Clinical Trial Optional)
  (NOT-EB-22-001)
  National Institute of Biomedical Imaging and Bioengineering
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan
  (NOT-OD-22-106)
  Office of Disease Prevention
  National Cancer Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Dietary Supplements
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening
  (NOT-OD-22-107)
  Office of Disease Prevention
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Dietary Supplements
  Office of Research on Women's Health
  

Funding Opportunities

• Competitive Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Enhance Workforce Diversity in Health Services Research
  (PA-22-175)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
  (PAR-22-105)
  National Cancer Institute
  National Center for Complementary and Integrative Health
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): May 07, 2025
  
  

• Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
  (PAR-22-106)
  National Cancer Institute
  John E. Fogarty International Center
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
  (PAR-22-109)
  National Cancer Institute
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): May 07, 2025
  
  

• Short-term Mentored Career Enhancement Award in Dental, Oral, and Craniofacial Research for Mid-Career and Senior Investigators (K18- Independent Clinical Trial Not Allowed)
  (PAR-22-121)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
  (PAR-22-160)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
  (PAR-22-167)
  National Center for Advancing Translational Sciences
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Dental and Craniofacial Research
  National Institute of General Medical Sciences
  National Institute on Minority Health and Health Disparities
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
  (PAR-22-182)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
  (PAR-22-183)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
  (PAR-22-184)
  National Institute of Neurological Disorders and Stroke
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-034)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 12, 2022
  
  

• Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)
  (RFA-AI-22-037)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 14, 2022
  
  

• Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)
  (RFA-CA-22-027)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed)
  (RFA-DA-23-027)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 10, 2022
  
  

• Educational Hub for Enhancing Diversity in Computational Genomics and Data Science (U24 Clinical Trials Not Allowed)
  (RFA-HG-22-002)
  National Human Genome Research Institute
  Application Receipt Date(s): July 27, 2022
  
  

• Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
  (RFA-NS-22-071)
  National Institute of Neurological Disorders and Stroke
  Office of the Director, NIH
  Application Receipt Date(s): June 17, 2022
  
  

• NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
  (RFA-RM-22-020)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 01, 2022